3

Use of Glycolysis-Enhancing Drugs and Risk of Parkinson's Disease

**Background:** Terazosin (TZ) and closely related α1-adrenergic receptor antagonists (doxazosin [DZ] and alfuzosin [AZ]) enhance glycolysis and reduce neurodegeneration in animal models. Observational evidence in humans from several databases …